Correlation Between Molecular Partners and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Bolt Biotherapeutics, you can compare the effects of market volatilities on Molecular Partners and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Bolt Biotherapeutics.
Diversification Opportunities for Molecular Partners and Bolt Biotherapeutics
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Molecular and Bolt is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and Bolt Biotherapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.75 times more return on investment than Bolt Biotherapeutics. However, Molecular Partners is 1.75 times more volatile than Bolt Biotherapeutics. It trades about 0.05 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.02 per unit of risk. If you would invest 448.00 in Molecular Partners AG on September 2, 2024 and sell it today you would earn a total of 134.00 from holding Molecular Partners AG or generate 29.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Bolt Biotherapeutics
Performance |
| Timeline |
| Molecular Partners |
| Bolt Biotherapeutics |
Molecular Partners and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Bolt Biotherapeutics
The main advantage of trading using opposite Molecular Partners and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| Bolt Biotherapeutics vs. Assembly Biosciences | Bolt Biotherapeutics vs. Instil Bio | Bolt Biotherapeutics vs. CytomX Therapeutics | Bolt Biotherapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |